Multiparameter in vitro assessment of compound effects on cardiomyocyte physiology using iPSC cells.
about
Tissue engineering the cardiac microenvironment: Multicellular microphysiological systems for drug screeningGeneration of highly purified human cardiomyocytes from peripheral blood mononuclear cell-derived induced pluripotent stem cellsA chemical-biological similarity-based grouping of complex substances as a prototype approach for evaluating chemical alternativesUse of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs) to Monitor Compound Effects on Cardiac Myocyte Signaling Pathways.Machine learning plus optical flow: a simple and sensitive method to detect cardioactive drugsIn vitro cardiotoxicity assessment of environmental chemicals using an organotypic human induced pluripotent stem cell-derived model.iPSCORE: A Resource of 222 iPSC Lines Enabling Functional Characterization of Genetic Variation across a Variety of Cell Types.Assessment of beating parameters in human induced pluripotent stem cells enables quantitative in vitro screening for cardiotoxicitySmall molecule screening in human induced pluripotent stem cell-derived terminal cell types.High throughput physiological screening of iPSC-derived cardiomyocytes for drug development.Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform.Pluripotent stem cells as a platform for cardiac arrhythmia drug screeningHuman stem cell-derived cardiomyocytes in cellular impedance assays: bringing cardiotoxicity screening to the front line.High-throughput drug profiling with voltage- and calcium-sensitive fluorescent probes in human iPSC-derived cardiomyocytes.Induced pluripotent stem cells: at the heart of cardiovascular precision medicine.Human Induced Pluripotent Stem Cells as a Platform for Personalized and Precision Cardiovascular Medicine.Convergence of Highly Resolved and Rapid Screening Platforms with Dynamically Engineered, Cell Phenotype-Prescriptive Biomaterials.Can Human Pluripotent Stem Cell-Derived Cardiomyocytes Advance Understanding of Muscular Dystrophies?Evaluation of Batch Variations in Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes from 2 Major Suppliers.High-Content Assessment of Cardiac Function Using Heart-on-a-Chip Devices as Drug Screening Model.Cardamonin, a Novel Antagonist of hTRPA1 Cation Channel, Reveals Therapeutic Mechanism of Pathological Pain.A non-invasive platform for functional characterization of stem-cell-derived cardiomyocytes with applications in cardiotoxicity testing.Bridging Functional and Structural Cardiotoxicity Assays Using Human Embryonic Stem Cell-Derived Cardiomyocytes for a More Comprehensive Risk Assessment.Stem cell derived in vivo-like human cardiac bodies in a microfluidic device for toxicity testing by beating frequency imaging.Enhanced characterization of contractility in cardiomyocytes during early drug safety assessment.High-Content Assay Multiplexing for Toxicity Screening in Induced Pluripotent Stem Cell-Derived Cardiomyocytes and HepatocytesAn Automated Platform for Assessment of Congenital and Drug-Induced Arrhythmia with hiPSC-Derived CardiomyocytesA Pipeline for High-Throughput Concentration Response Modeling of Gene Expression for Toxicogenomics.Machine Learning of Human Pluripotent Stem Cell-Derived Engineered Cardiac Tissue Contractility for Automated Drug Classification.Evaluation of drug-mediated arrhythmic changes in spontaneous beating cardiomyocytes by AFM.The Need for, and the Role of the Toxicological Chemist in the Design of Safer Chemicals.Human pluripotent stem cell-derived cardiomyocyte based models for cardiotoxicity and drug discovery.Multielectrode Array (MEA) Assay for Profiling Electrophysiological Drug Effects in Human Stem Cell-Derived Cardiomyocytes.On-chip spatiotemporal electrophysiological analysis of human stem cell derived cardiomyocytes enables quantitative assessment of proarrhythmia in drug development
P2860
Q26799470-33ADADA9-74F1-437A-A354-279D0248279DQ27307424-0CFD1575-4DF4-4916-8AFE-FA9883FF0FE6Q28818732-FF6B7F20-6355-4CED-9F8F-654665F8DA6BQ30402943-1BAB8E68-E4EE-4D8A-BB0C-66969CBE4E04Q30656460-072548E3-FAF0-43B2-941F-BCE5BDE987D7Q32181083-6DAFD361-8B38-4B16-AB55-16D5635A7FC0Q33559864-6619B432-CCBD-40A2-9C2A-4BFAA1A5A742Q35008383-C3225E68-3304-4353-AD8F-826EB00534A9Q35074117-C3E0953D-2D73-4539-96C7-4259D42E6F1EQ36948480-56569CB7-66AC-4B49-9A54-CCE7B0CDEED9Q37573646-5574B80A-639D-4EBA-BBF1-FDAA18E7AF27Q38235190-E2975479-C396-40E2-930F-59B85DA1B0D2Q38240972-BB480D63-087F-4A31-A9E6-E1D06B67774FQ38769738-EA5DF705-C744-41C1-8D38-7D1D35F7473DQ38786687-55F9CA9F-4DB9-4189-ADC9-E60CFC9B46DAQ38874111-07DA0AD0-B20D-492F-B436-658BEAA61820Q38915910-2211C7E3-BEE4-42A4-8ADB-9493CAD946F8Q39010745-CAFBF2BD-1A69-434E-9235-C50A04BC2DE3Q39056543-A49C4B95-5E07-4EA8-AB21-94FCACB55AD1Q39253982-4C688DA7-9A45-4895-9335-ADD46E618B5EQ39427896-B6858741-2E98-4ED9-B2F4-61EF54A04FEFQ39723101-038FCBBC-025C-4E83-A4CE-4B03D6A8FF0BQ40640593-99E06B21-1540-49DF-979E-364FFB91CB26Q40775564-520E7BB0-CCBC-4541-9790-F415A2327591Q41144260-99AE6F8E-4A4A-4ACC-913A-CFE41859416EQ41927296-159A78C1-9E34-454C-97D1-BA02B779EFE6Q42700209-D85564C0-A8BA-4095-892D-3E83894373D9Q44877273-C3762174-40EC-4ED6-B67F-12AC187420E8Q45944962-CF973BBF-1CB4-4B4F-A425-DE9DF0913A01Q46467904-47B69182-C67F-40BE-8CA4-E97E33C7FB60Q50065411-2B148601-D69F-4A09-BD03-54408DBE6577Q51134011-3B6E63AB-5E70-4354-80C7-9D294FBBA8ACQ54327084-B177F27F-E8AD-4F15-846E-E6539CB8CB07Q59126210-80FC1094-828C-4362-9C06-B63E52E92B88
P2860
Multiparameter in vitro assessment of compound effects on cardiomyocyte physiology using iPSC cells.
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Multiparameter in vitro assess ...... e physiology using iPSC cells.
@ast
Multiparameter in vitro assess ...... e physiology using iPSC cells.
@en
Multiparameter in vitro assess ...... e physiology using iPSC cells.
@nl
type
label
Multiparameter in vitro assess ...... e physiology using iPSC cells.
@ast
Multiparameter in vitro assess ...... e physiology using iPSC cells.
@en
Multiparameter in vitro assess ...... e physiology using iPSC cells.
@nl
prefLabel
Multiparameter in vitro assess ...... e physiology using iPSC cells.
@ast
Multiparameter in vitro assess ...... e physiology using iPSC cells.
@en
Multiparameter in vitro assess ...... e physiology using iPSC cells.
@nl
P2093
P2860
P356
P1476
Multiparameter in vitro assess ...... e physiology using iPSC cells.
@en
P2093
Blake Anson
Carlos Funes
Carole Crittenden
Evan F Cromwell
Ivan Rusyn
Jayne Hesley
Nick Callamaras
Oksana Sirenko
Yen-Wen Chen
P2860
P356
10.1177/1087057112457590
P577
2012-09-12T00:00:00Z